Copyright
©The Author(s) 2004.
World J Gastroenterol. Aug 15, 2004; 10(16): 2344-2351
Published online Aug 15, 2004. doi: 10.3748/wjg.v10.i16.2344
Published online Aug 15, 2004. doi: 10.3748/wjg.v10.i16.2344
Figure 6 PSCs were treated with HNE (at 0, 1, or 5 μmol/L ) in the absence or presence of PDGF (at 25 ng/mL) in serum-free medium.
After 24-h incubation, cells were labeled with BrdU for 3 h. Cells were fixed, and incubated with peroxidase-conju-gated anti-BrdU antibody. Then the peroxidase substrate 3,3’, 5,5’-tetramethylbenzidine was added, and BrdU incorporation was quantitated by differences in absorbance at wavelength 370 min 492 nm (“A.”, optical density). Data are shown as mean ± SD (n = 6). bP < 0.01 versus control (serum-free medium only), N.S.: not significant.
- Citation: Kikuta K, Masamune A, Satoh M, Suzuki N, Shimosegawa T. 4-hydroxy-2, 3-nonenal activates activator protein-1 and mitogen-activated protein kinases in rat pancreatic stellate cells. World J Gastroenterol 2004; 10(16): 2344-2351
- URL: https://www.wjgnet.com/1007-9327/full/v10/i16/2344.htm
- DOI: https://dx.doi.org/10.3748/wjg.v10.i16.2344